Zepbound (Tirzepatide) Vomiting: Supplements With the Best Evidence

How Common Is Vomiting on Zepbound?

In pooled weight-reduction trials, vomiting occurred in 8% on 5 mg, 11% on 10 mg and 13% on 15 mg, versus 2% on placebo [3]. Most nausea, vomiting and diarrhea occurred during dose escalation and decreased over time [3]. The label says Zepbound is not recommended in severe gastroparesis [3].

What the Supplement Evidence Shows

Ginger and vitamin B6 were studied for pregnancy-related nausea and vomiting, a different cause of vomiting than Zepbound [1][2]. None of the supplement trials below enrolled people taking tirzepatide.

Ginger

A 12-trial review in 1,278 pregnant women found ginger improved nausea versus placebo (mean difference 1.20, 95% CI 0.56 to 1.84, P=0.0002) but did not significantly reduce vomiting episodes (mean difference 0.72, 95% CI -0.03 to 1.46, P=0.06) [1]. One single-blind trial in 67 pregnant women used 250 mg capsules for four days, a daily total of 1,000 mg; nausea improved in 85% vs 56% (P<0.01), and vomiting times fell 50% vs 9% (P<0.05) [6].

Vitamin B6

In a double-blind trial, 59 pregnant women received pyridoxine 25 mg every 8 hours for 72 hours or placebo [2]. Among women with severe nausea, nausea-score improvement was 4.3 vs 1.8 (P<0.01); in mild to moderate nausea and the whole group, nausea improvement was not significantly different from placebo [2]. Before treatment, 15 of 31 women in the vitamin B6 group and 10 of 28 in the placebo group had vomiting; at three days, 8 of 31 on vitamin B6 had any vomiting vs 15 of 28 on placebo (P<0.05) [2].

Magnesium and L-Theanine

A review of magnesium in type 2 diabetes discusses magnesium deficits and insulin action but reports no nausea or vomiting outcomes [4]. A 2019 crossover trial in 30 healthy adults tested L-theanine 200 mg/day for four weeks and measured stress, sleep and cognition, not vomiting [5].

What Does the Label Say to Watch For?

The label describes acute pancreatitis signs as persistent or severe abdominal pain, sometimes radiating to the back, with or without nausea or vomiting, and says to discontinue Zepbound if pancreatitis is suspected [3]. It also warns about acute kidney injury from volume depletion and says to monitor renal function in patients reporting reactions that could lead to volume depletion, especially during dose initiation and escalation [3].